New Biotechnological Treatments for Lipid Disorders
نویسندگان
چکیده
منابع مشابه
Behavioral Treatments for Sleep Disorders
This therapeutic approach is indicated specifically for individuals with evidence of dysfunctional sleep cognitions and, particularly, faulty sleep-related beliefs. There is no evidence that it is more or less effective for specific subtypes of insomnia (initial, middle, mixed) or diagnostic subgroups (primary or comorbid insomnia). Clinically, cognitive therapy is likely to be more helpful for...
متن کاملBehavioral Treatments for Sleep Disorders
CONTRAINDICATIONS There are no specific contraindications for this technique. However, there are contraindications for the MBTI program. Individuals with a current psychiatric diagnosis of major depressive disorder, bipolar disorder, psychotic disorder, post-traumatic stress disorder, and substance abuse or dependence are not appropriate candidates for MBTI because these conditions are likely t...
متن کاملBehavioral Treatments for Sleep Disorders
There is no evidence to suggestion that Paradoxical Intention (PI) therapy is differentially effective in the sleep onset and sleep maintenance insomnia subtypes. The rationale for PI therapy, however, seems particularly appropriate for the psychophysiological insomnia phenotype (as stated above). There are two studies that suggest that reduction of sleep-related anxiety and performance effort ...
متن کاملNonpharmacological treatments for anxiety disorders
An evidence-based review of nonpharmacological treatments for anxiety disorders is presented. The vast majority of the controlled research is devoted to cognitive behavior therapy (CBT) and shows its efficiency and effectiveness in all the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) anxiety disorders in meta-analyses. Relaxation, psychoanalytic therapies, Roge...
متن کاملTreatments for lysosomal storage disorders.
There are over 70 human diseases that are caused by defects in various aspects of lysosomal function. Until 20 years ago, the only specific therapy available for lysosomal storage disorders was allogeneic haemopoietic stem cell transplantation. Over the last two decades, there has been remarkable progress and there are now licensed treatments for seven of these diseases. In some cases, a choice...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista de investigaci�n Cl�nica
سال: 2018
ISSN: 0034-8376
DOI: 10.24875/ric.18002577